Global Non-Invasive Prenatal Testing Market Forecast Report Revenue, Demand and Trend Analysis Research Report by 2027
Global Non-Invasive Prenatal Testing Market Expected to Reach USD 8.75 Billion by 2027
SURREY, BRITISH COLUMBIA, CANADA, March 14, 2022 /EINPresswire.com/ — The latest market information report titled “Global Non-Invasive Prenatal Testing Market” aims to provide the target audience with necessary information about the global Non-Invasive Prenatal Testing Industry market. The growth of Non-Invasive Prenatal Testing (NIPT) industry is driven by high probability of chromosomal abnormalities with high maternal age, increased demand for non-invasive procedures over invasive approaches, improved NIPT reimbursement scenario and better understanding of NIPT. Prenatal Testing Market Size – USD 3.08 billion in 2019, Noninvasive Prenatal Testing Market Growth – CAGR of 13.9%, Noninvasive Prenatal Testing Market Trends – High demand from developing countries.
The report offers accurate information about market price, capacity, value, gross revenue and profit. The main objective of the report is to offer in-depth details about market size, revenue growth and overall market dynamics to readers, stakeholders and businesses to enhance their share in the global Prenatal Testing market non-invasive. It also provides detailed information regarding key drivers, restraints, limitations, challenges along with various market segmentations such as product type, application and regional bifurcation.
To know more about the report @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Purpose of the report:
The report offers a comprehensive analysis of the global Non-Invasive Prenatal Testing Market with details about each market player including company profile, financial status, global position, revenue contribution, production capacity and manufacturing, business expansion plans and new product launches. The major players are strategizing for various plans such as M&A acquisition, partnerships, joint ventures, licensing agreements, and collaborations. top companies profiled in the report.
Although NIPT is accessible in a growing number of regions, a major commercial push is expected to drive consumer expansion in the projected years. NIPT was confirmed by similarities to standard prenatal screening for aneuploidy and found to be a beneficial screening procedure with high sensitivity and specificity. Growing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic issues are driving noninvasive prenatal testing.
The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region and presence. of key players in the region.
NGS technology, along with cfDNA research, has paved the way for identifying chromosomal aberrations with increasing efficiency and reduced expense. The high-risk testing industry is overcrowded and continued rivalry is likely to result in substantial drops in the retail price of such tests. The prevalence of such studies can be improved with reduced costs in the reproductive genetics market. The creation of new technologies for NIPT is gradually increasing due to the growing awareness of the benefits of non-invasive methods.
Based on the method, Ultrasonic Detection generated revenue of USD 0.86 billion in 2019 and is expected to grow with a CAGR of 14.0% during the forecast period, owing to capacity from ultrasound diagnostics to detecting abnormalities in the baby’s position and actions. in the womb.
The hospital segment is expected to grow with a CAGR of 14.1% over the forecast period owing to the increasing introduction of non-invasive prenatal tests coupled with rapid technological developments and breakthrough acceptance strategies.
The trisomy app is the leading contributor to the non-invasive prenatal testing market. The North America region Down syndrome application is the largest market shareholder and held approximately 45.1% of the market in 2019, due to the high incidence of genetic disorders correlated with Down syndrome, such as Patau syndrome, Down syndrome and Edward syndrome.
North America dominated the non-invasive prenatal testing market in 2019 owing to the availability of a state-of-the-art healthcare research system, the region’s WGS production. The North America region held around 48.8% of the market, followed by Europe, which held around 25.4% of the market in 2019.
The main participants are Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI and Natera Inc., among others.
Global Non-Invasive Prenatal Testing Market Segmentation
For the purposes of this report, Emergen Research has segmented the global non-invasive prenatal testing market based on method, end-use, application, and region:
Method Outlook (Revenue, USD Billion; 2017-2027)
Biochemical screening tests
Cell-Free DNA in Maternal Plasma Tests
End-Use Outlook (Revenue, USD Billion; 2017-2027)
Application Outlook (Revenue, USD Billion; 2017-2027)
Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/16
Summary of key points from the report:
The report offers a comprehensive overview of the market size, share, and growth rate over the forecast duration.
It provides details of the current scenario, historical data, giving an accurate forecast of the market for the coming years.
The study categorizes the market based on product types, applications, end-users, market value and volume, industry verticals, and 5 major regions.
It also offers regional market analysis and forecasts for the major geographies of the industry i.e. North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. .
Industry supply chain, sourcing strategy, upstream raw materials and downstream demand analysis have also been undertaken in the research report.
The study offers a comprehensive understanding of demand and supply dynamics, including production and consumption rates, and overall market mapping.
The report uses different analytical tools including SWOT analysis, Porter’s five forces analysis, and price analysis to provide accurate market insights.
The regional segmentation includes current and forecast estimation of the market in key geographical regions such as North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 1: Methodology and scope
Definition and forecast parameters
Methodology and forecast parameters
Technology and innovation landscape
Click here for customization: https://www.emergenresearch.com/request-for-customization/16
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Medical Radiation Detection, Monitoring and Safety Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in healthcare: https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.
Corporate Sales Specialist
Emerging Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Email: [email protected]
Facebook | LinkedIn | Twitter | Blogs
+91 90210 91709
write to us here
Visit us on social media: